跳至主要内容
临床试验/NCT04083482
NCT04083482Unknown不适用

Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis

First People's Hospital of Chenzhou1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2018年8月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Change of mtDNA concentration in plasma

研究概览

简要总结

The plasma level of mtDNA in sepsis is affected by continous venovenous hemofiltation(CVVH)

详细描述

Continous renal replacement therapy (CRRT)has become routine for patients with chronic renal failure ,AKI,fliud overload as well as oliguria in ICU .In clinical patients ,continous venovenous hemofoiltration (CVVH)is actually the method of chioce for CRRT in critically ill and hemodynamic instable patients .CVVH has significant beneficial effects on removing inflammatory cytokines ,improving oxygen index,increasing cardiac index and regulating immune dysfuntion .

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult septic patients undergoing CRRT

排除标准

  • Missing vists
  • transplatation
  • aquired immunodeficiency syndrome

研究组 & 干预措施

Septic patients require CVVH

Experimental

continuous venovenous hemofiltration. Continuous renal replacement therapy(CRRT)has become routine for patients with chronic renal failure ,AKI,fliud overload as well as oliguria in ICU .Continuous venovenous hemofiltration(CVVH)is the method of chioce for CRRT in critical ill .CVVH has significant beneficial effects on removing inflammatory cytokines ,improving oxygen index ,decreasing vasopressor requirements,increasing cardiac index and regulating immune dysfunction .

干预措施: continous venovenous hemofiltraion (Procedure)

结局指标

主要结局

Change of mtDNA concentration in plasma

时间窗: befor,6hours, 12hours, after CVVH treatment

The specimens in the prefilter and postfilter blood as well as in the ultrafiltrate were obtained at the beginning of CRRT (T0) and 6 h (T6h), 12 h (T12h) after the setup of CVVH.

次要结局

未报告次要终点

研究者

发起方
First People's Hospital of Chenzhou
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xingui Dai

Critical Care Medicine

First People's Hospital of Chenzhou

研究点 (1)

Loading locations...

相似试验